ONO PHARMA USA Announces 2025 Golden Ticket CompetitionNow Accepting Applications from Innovative Startups
Ono Partnering with LabCentral and MBC BioLabs for Fifth Consecutive Year
CAMBRIDGE, Mass., April 26, 2025 /PRNewswire/ — ONO PHARMA USA today announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San Carlos, CA to award each organization one Golden Ticket for an innovative life sciences startup company. The competition is sponsored by ONO PHARMA USA's parent company, Ono Pharmaceutical Co., Ltd. (Ono), and applications will be received through May 2025.
The Golden Ticket awards provide two promising early-stage R&D companies lab space and mentorship, components that are vital to the success of promising life science businesses. The competition seeks proposals from startup companies in the oncology, immunology, neurology, and specialty areas. The Golden Tickets Ono is sponsoring will provide one outstanding applicant lab space and related services at each of the partner locations, as well as mentorship from Ono's renowned researchers and business leaders across its global network. LabCentral and MBC BioLabs have partnered with Ono since 2021. Eight companies have won a Golden Ticket, including Leverna, a biotech based in Cambridge, Mass., that specializes in the RNA regulatory processes and regulate gene expression and protein function, and DeepSeq.AI, a San Francisco biotech dedicated to creating new antibody/protein with generative AI and data generation.
Interested applicants may submit their non-confidential company presentations to:
LabCentral, by May 30, to: https://www.labcentral.org./. The Golden Ticket winner will receive a $50,000 credit towards space available at LabCentral's flagship site in Kendall Square for use within a 13-month period, beginning upon receipt. Residents have access to a full range of services, equipment, and amenities. MBC BioLabs, by June 6, to: https://mbcbiolabs.com/featured/ono-golden-ticket-2025/. Winners will receive one-year free lab space at MBC BioLabs in San Francisco and San Carlos, and access to its shared amenities and services.
Initial submissions will be accepted for each location, Cambridge, San Francisco and San Carlos, and reviewed by Ono's internal committee. Finalists for each location will be notified and invited to present to Ono in person or virtually at the end of July. Winners will be presented with the Golden Tickets shortly after that.
In 2021, Ono entered sponsorship agreements with LabCentral and MBC BioLabs, organizations that support the development of biotech startups and entrepreneurs by providing access to comprehensive laboratory facilities and technologies. Ono has long been a proponent of collaboration in R&D and credits its open innovation model for supporting key scientific breakthroughs over the years.
'As longtime believers in open innovation and the power of partnerships, we are excited to be partnering with LabCentral and MBC BioLabs to offer this Golden Ticket competition,' said Kunihiko Ito, President and CEO of ONO PHARMA USA. 'We encourage companies who are doing outstanding work in Ono's four focus areas – oncology, immunology, neurology, and specialty medicine – to apply. It's our goal to deliver first-in-class medicines to patients who are waiting for them, by leveraging startup technology and Ono's expertise.'
About ONO PHARMA USA
ONO PHARMA USA, established in 1998 as the U.S. subsidiary of Ono Pharmaceutical Co., Ltd., is pursuing the clinical development of new drug candidates. In addition, ONO PHARMA USA is engaged in promotion of the discovery alliances and licensing activities to expand Ono's development pipeline and pursue the commercialization opportunities in the U.S. For more information, please visit https://us.ono-pharma.com/.
About Ono Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co., Ltd. delivers innovative therapies for patients worldwide. Upholding its philosophy of 'Dedicated to the Fight against Disease and Pain,' Ono targets areas with unmet medical needs including oncology, immunology and neurology, and fosters partnerships with academic and biotech organizations to accelerate drug discovery. Through its affiliate, Deciphera Pharmaceuticals, Ono is accelerating clinical development and commercial operations in the US and Europe to drive global business expansion and further its commitment to patient care. For more information, please visit the company's website at https://www.ono-pharma.com/en.
About LabCentral
A private, non-profit institution, LabCentral is a launchpad for high potential life-sciences and biotech startups with 225,000 square feet of space across Kendall Square in Cambridge, Mass., and the Harvard University campus. Founded in 2013, LabCentral offers a full complement of programming and networking to life sciences entrepreneurs in addition to fully permitted laboratory and office space for early stage and growing life sciences companies. More information is available at www.labcentral.org.
About MBC BioLabs
MBC BioLabs is dedicated to helping life-science startups succeed. By renting space as small as a single lab bench and providing these entrepreneurial scientists with access to millions of dollars of equipment, MBC BioLabs allows companies to be fast, focused, and frugal. It has five sites: two in the Mission Bay neighborhood in San Francisco and three campuses in San Carlos, California. Each site has a complete molecular biology core facility that allows companies to do experiments on day one. MBC BioLabs has partnerships with leading pharmaceutical and life-science companies as well as a built-in venture capital firm, Mission BioCapital. These partnerships provide entrepreneurs with valuable insights about where to focus their efforts and accelerates the innovation pipeline. Since opening in 2013, MBC BioLabs has helped launch and grow over 350 companies. These companies have brought over 175 programs into the clinic, produced 13 approved diagnostics, and raised over $20 billion. For more information, please visit the website at www.mbcbiolabs.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Express
10 hours ago
- Daily Express
Sandakan hosts crucial Mapex
Published on: Friday, June 13, 2025 Published on: Fri, Jun 13, 2025 By: Winnie Kasmir Text Size: Phoong (second, left) visiting one of the booths at the event. SANDAKAN: The second edition of the Malaysia Palm Oil Expo (Mapex) 2025 in Sandakan has been hailed as a crucial platform for industry players to connect, exchange insights, and explore future growth opportunities in Sabah's palm oil and biomass sectors, said Sabah's Minister of Industrial Development and Entrepreneurship, Datuk Ginger Phoong Jin Zhe. Speaking at the opening ceremony of the event, Phoong emphasised that the palm oil industry is at a turning point, where numerous opportunities are emerging particularly in renewable energy and sustainable industry practices. Advertisement 'I'd like to congratulate the organisers. Mapex provides an opportunity for us to think together and move the industry forward. 'It allows stakeholders to discuss pressing issues such as renewable energy, green practices, and certification processes, especially given the various challenges facing Sabah's palm oil sector,' he said. He urged industry players to tap into the potential of downstream activities and the development of the palm biomass sector in Sabah. 'I've just returned from Osaka, Japan, where I met several companies expressing serious interest in investing in Sabah's biomass industry. 'This reflects growing global confidence in our resources and long-term potential,' he added. Phoong also highlighted Sandakan's strategic location within the palm oil supply chain and called for greater investment, both local and international to accelerate economic development in the region. 'We want to attract major investors to Sabah, particularly to Sandakan. More investments mean more factories, more job opportunities, and overall economic growth. 'Events like Mapex are not only investment platforms but also an avenue to showcase Sandakan to the international market,' he said. He concluded by expressing hope that Mapex and similar events will continue to be held regularly to further boost Sabah's position as a leading hub for sustainable palm oil and biomass development. Mapex 2025 which held from 11 to 12 June at Hakka Hall brings together an international congregation of both upstream and downstream palm oil companies, along with their supporting industries to Sandakan. This expo highlights the latest developments and innovations in the palm oil sector, reflecting the significant role East Malaysia plays in the industry. * Follow us on our official WhatsApp channel and Telegram for breaking news alerts and key updates! * Do you have access to the Daily Express e-paper and online exclusive news? Check out subscription plans available. Stay up-to-date by following Daily Express's Telegram channel. Daily Express Malaysia
Barnama
11 hours ago
- Barnama
'UTM Rocketry Team' Creates History By Reaching IREC 2025 Finals
JOHOR BAHRU, June 13 (Bernama) -- A group of Universiti Teknologi Malaysia (UTM) students created history by launching their homemade rocket "RIMAU-1" in the International Rocket Engineering Competition (IREC) 2025, currently taking place in Midland, Texas, in the United States. UTM said in a statement that this achievement makes the university the first Malaysian team to advance to the final stages of this prestigious six-day competition, organised by the Tripoli Rocketry Association, which is ending tomorrow (June 14) thereby bringing honour to the country on the global stage. According to the statement, the team known as the UTM Rocketry Team, led by mechanical engineering final-year student T K Arykummara together with teammates Brenden Huang Hong Quan, K Raahull, Izzat Idlan Amir Raslan and S N Shivee Prakkaash, who represent a combination of students from the mechanical engineering and electrical engineering faculties. "Interestingly, the team also developed a rocket parachute system as a safety measure, in addition to using ammonium perchlorate as the main propulsion system to reach the target altitude of 3,000 metres (m) in Texas airspace. "In addition, the cost of constructing RIMAU-1 is estimated at RM40,000, while the total cost including travel and logistics reaches RM200,000. (Moreover) this project also received support and financial assistance from the Faculty of Mechanical Engineering, the Office of the Deputy Vice-Chancellor for Student Affairs (JTNCHEPA), UTM International (UTMI) as well as several other sources," said the statement. Meanwhile, Arykummara in the same statement said the rocket named RIMAU-1, which is 2.8 m in height and weighs 28 kilogrammes, was built using fiberglass and carbon material, and is expected to reach a maximum height of up to 3,000 m in accordance with the height requirements set by the organisers. He said the process to build the rocket was not just about assembling components but involved intensive research, repeated testing, and meticulous attention to every technical and safety aspect. "The handmade rocket took a total of more than nine months to build and was the result of teamwork, consisting of 40 people from various technical disciplines. The project began early testing in January and was only seriously worked on starting in March, with an intensive two-month construction period. "Therefore, this participation is not just a competition, but a symbol of our team's spirit of innovation, resilience, and cooperation bringing the Malaysian spirit to the international stage," said Arykummara.
Sinar Daily
a day ago
- Sinar Daily
High-profile cases now wrapped up in six months
One of the main factors that enabled the shorter investigation period was the improvement of investigation modules and systems by reviewing outdated elements in the commission's procedures. 12 Jun 2025 05:06pm MACC chief commissioner Tan Sri Azam Baki during a press conference after the second Convocation Ceremony of the MACC's Certified Law Enforcement Programme, today. - Photo by Bernama BANGI - The Malaysian Anti-Corruption Commission (MACC) has shortened the investigation period for high-profile cases from one and a half years to just six months, thanks to the implementation of new approaches, including upskilling officers and utilising the latest technology. MACC Chief Commissioner Tan Sri Azam Baki said one of the main factors that enabled the shorter investigation period was the improvement of investigation modules and systems by reviewing outdated elements in the commission's procedures. "In the past, one high-profile case could take us about one and a half years to complete the investigation papers, but now we can complete them within six months. Secondly, we enhance our officers' skills and knowledge. "About 10 years ago, we needed to dispatch many officers to conduct surveillance. But now, we just use technology to locate suspects and witnesses. So, in a very short period, we can locate the suspect or the person we want to find,' he said. MACC chief commissioner Tan Sri Azam Baki during a press conference after the second Convocation Ceremony of the MACC's Certified Law Enforcement Programme, today. - Photo by Bernama Azam said this at a press conference after attending the 2025 MACC-NTU International Law Enforcement Programme Convocation here today. In addition, Azam said the MACC has also established strategic collaborations with external parties to strengthen its investigation capabilities, especially in technical aspects and financial forensics. He said international cooperation also plays a vital role, particularly in tracing and recovering assets located abroad. "We also collaborate with many parties. For example, our collaboration with the Malaysian Institute of Accountants helps us with asset tracing and forensic accounting," he said. On the need to increase staffing, Azam said that although there was a rise in the number of reports from 2020 to April 2025, totalling 34,819, mass recruitment of MACC officers is not the primary solution to strengthening anti-corruption efforts. "I do not see that adding a large number of MACC officers is the solution to combat corruption in this country. The most important thing is our approach,' he said, adding that during the same period, 5,145 investigation papers were opened, leading to the arrest of 5,703 individuals. He said that out of these arrests, 2,479 individuals were prosecuted and 1,274 were subsequently convicted in court. The MACC also recorded significant financial enforcement outcomes, including the seizure of RM3.54 billion in assets and the forfeiture of an additional RM27.87 billion. At today's convocation, 250 people graduated from the programme, and they have now been appointed as new MACC officers. - BERNAMA
